EcoDrugPlus

Casein Kinase 1 Epsilon

Ensembl ID : ENSUAMG00000007622
Gene Symbol: CSNK1E
1 Cross references
268 Possible Orthologues:

Caspase 8

Ensembl ID : ENSUAMG00000006848
Gene Symbol: CASP8
2 Cross references
132 Possible Orthologues:

Caspase 9

Ensembl ID : ENSUAMG00000017743
Gene Symbol: CASP9
2 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSUAMG00000010900
Gene Symbol: COMT
2 Cross references
275 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSUAMG00000007663
Gene Symbol: CTSC
2 Cross references
233 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSUAMG00000010381
Gene Symbol: CTSK
2 Cross references
240 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSUAMG00000010384
Gene Symbol: CTSS
2 Cross references
269 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSUAMG00000008761
Gene Symbol: CDC7
2 Cross references
208 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSUAMG00000006296
Gene Symbol: CHEK1
2 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSUAMG00000011246
Gene Symbol: CHEK2
2 Cross references
205 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSUAMG00000016444
Gene Symbol: CCKAR
2 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSUAMG00000024011
Gene Symbol: CCKBR
2 Cross references
264 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).